• About Us
  • Contact Us
  • Photo Gallery
  • Privacy Policy
  • Terms of Use
  • Citi TV
Sunday, December 10, 2023
Citinewsroom - Comprehensive News in Ghana
  • Home
  • News
  • Business
  • Sports
  • Showbiz
  • Opinion
  • Infographics
  • Listen To CitiFM
  • Watch Citi TV
  • Videos
No Result
View All Result
Citinewsroom - Comprehensive News in Ghana
  • Home
  • News
  • Business
  • Sports
  • Showbiz
  • Opinion
  • Infographics
  • Listen To CitiFM
  • Watch Citi TV
  • Videos
No Result
View All Result
Citinewsroom - Comprehensive News in Ghana
No Result
View All Result

Coronavirus: UK scientists start mass production of vaccines while trials are still under way

April 17, 2020
ShareShareShareShare

British scientists have said they hope to have one million doses of a coronavirus vaccine ready to be deployed by September.

The team at Oxford University will start the first UK study of an experimental vaccine against COVID-19 next week.

But so great is the need, and so high their confidence that it will work, that they will start large-scale production before the trials are even complete.

Professor Adrian Hill, director of Oxford University’s Jenner Institute, said the world could not afford to wait for vaccines to be proven to be safe and effective in trials that would involve months of delay before production starts.

He told Sky News: “While those trials are going on we have to start manufacturing, manufacturing at risk because if the vaccine fails nobody will want the doses.

“But the hope is to have about a million doses by September ready for deployment.

“It’s a big ask, but not impossible.”

The Oxford team say there is an 80% chance of success. If trials are positive hundreds of millions of doses could be ready by the end of the year.

The vaccine, called ChAdOx1 nCoV-19, is made from a harmless chimpanzee virus that has been genetically engineered to carry part of the coronavirus. The technique has already been shown to generate strong immune responses in other diseases.

Deals have already been done with three UK manufacturers, and several more abroad, to make the vaccine.

The scientists have been awarded £2.2m to fund clinical trials by the government’s new vaccine taskforce, which aims to speed up their development and manufacture.

A separate team at Imperial College London has also been backed by government money.

But no deal has been done by Whitehall to secure supply of any vaccine doses.

In answer to a question by Sky News at the daily virtual government news briefing, Sir Patrick Vallance, the UK’s chief scientific adviser, said: “Just to put some realism on vaccine development, each single project does not have a high probability of success.

“So although everybody goes out with high enthusiasm and we hope they work it’s never the case that you know you have a vaccine that is going to work.

“The vaccine could come from anywhere – most of the big (pharmaceutical) companies are doing vaccines.

“We need to back lots of horses so we are in the position to access a vaccine when it occurs.”

More than 70 experimental vaccines are in development around the world.

Two in the United States and one in China have already begun safety studies.

Source: Sky News
Tags: Coronavirus vaccineMass productionTrialsUK Scientists
Previous Post

COVID-19: Parliament approves IMF’s $1bn interest-free loan for Ghana

Next Post

Electricity relief for Ghanaians to cost GHS1 billion

Next Post
Electricity metre

Electricity relief for Ghanaians to cost GHS1 billion

TOP STORIES

Ghana’s Anita Kiki Gbeho appointed deputy Head of AU-UN mission in South Sudan

December 9, 2023

Seven Headteachers in Ashanti Region interdicted for charging unauthorized fees

December 9, 2023

Kpone-Katamanso: Over 100 residents left homeless after overnight demolition at Santeo

December 9, 2023
Load More
ADVERTISEMENT
Citinewsroom - Comprehensive News in Ghana

CitiNewsroom.com is Ghana's leading news website that delivers high quality innovative, alternative news that challenges the status quo.

Archives

Download App

Download

Download

  • About Us
  • Contact Us
  • Photo Gallery
  • Privacy Policy
  • Terms of Use
  • Citi TV

© 2023 All Rights Reserved Citi Newsroom.

No Result
View All Result
  • Home
  • News
  • Business
  • Sports
  • Showbiz
  • Opinion
  • Infographics
  • Listen To CitiFM
  • Watch Citi TV
  • Videos

© 2023 All Rights Reserved Citi Newsroom.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT